Promotion of indigenous pharmaceutical manufacturing
PLI scheme for Bulk Drugs has a total budgetary outlay of Rs. 6,940 crore
PLI scheme for Bulk Drugs has a total budgetary outlay of Rs. 6,940 crore
Biocon Foundation is also expanding its reach with this first initiative in Channapatna region
The company reported revenue from operations at Rs. 6,573.7 crore, up 6 per cent YoY
This achievement is part of the population-based initiative for screening, prevention, and management of Non-Communicable Diseases
The facility will manufacture 13,200 MTPA Benzyl Chloride, 9,600 MTPA Benzyl Alcohol, and 7,200 MTPA Benzaldehyde
Dilip Shanghvi to continue as the Executive Chairman of the Board
Biotech potential of Himalayan territories including Jammu & Kashmir, particularly their agri-biotech potential remains still under-explored
Till 30th November 2024, more than 2690 PACS have been given initial approval and 687 Kendras have been opened in PACS
Subscribe To Our Newsletter & Stay Updated